Hypertension : β blockers are relatively mild antihypertensives. All agents, irrespective of associated properties, are nearly equally effective. They are one of the first choice drugs because of good patient acceptability and cardioprotective potential.
USES
β blockers are
relatively mild antihypertensives. All
agents, irrespective of associated properties, are nearly equally effective.
They are one of the first choice drugs because of good patient acceptability
and cardioprotective potential.
All β blockers benefit
angina of effort. Taken on a
regular schedule they decrease frequency of attacks and increase exercise
tolerance. High doses, however, may worsen angina in some patients by
increasing ventricular size and reducing coronary flow.
3. Cardiac Arrhythmias
β blockers suppress extrasystoles and
tachycardias, especially those mediated adrenergically (during anaesthesia,
digitalis induced)—may be used i.v. for this purpose. They control ventricular
rate in atrial fibrillation and flutter, but only occasionally restore sinus
rhythm. Esmolol is an alternative drug for paroxysmal supraventricular
tachycardia.
In relation to MI, β blockers have been
used for two purposes:
a. Secondary prophylaxis of MI: There is now firm evidence of benefit. Longterm use after
recovery from MI has been found to decrease subsequent mortality by 20%.
o By preventing
reinfarction
o By preventing sudden
ventricular fibrillation at the second attack of MI.
High
risk patients (those who had large infarcts) should be put on β blockers (if there
are no haemodynamic contraindications) for at least 2 years. β blockers with partial
agonistic action are less suitable for this purpose.
b.
Myocardial salvage during evolution of MI:
Administered i.v. within 4–6 hours of an attack followed by continued
oral therapy. β blockers—
·
May limit infarct size by reducing O2
consumption—marginal tissue which is partially ischaemic may survive.
·
May prevent arrhythmias including ventricular
fibrillation.
However,
β blockers can be given
to only those patients not in shock or cardiac failure and who have heart rate
> 50/min with not higher than first degree heart block (PR interval <
0.24 sec). In megatrials such therapy has been found to reduce mortality by
20–25%.
Although β blockers can acutely worsen heart failure, several
studies have reported beneficial haemodynamic effects of β1 blockers over longterm
in selected patients with dilated cardiomyopathy. Introduced gradually and
maintained for long term, these drugs retard the progression of CHF and prolong
life. The benefit may result from antagonism of deleterious effects of sympathetic
overactivity on myocardium. Overactivation of cardiac β1 receptors has been
found to exert toxic effects on the heart by accelerating myocyte apoptosis and
promoting functionally unfavourable remodeling. Certain β1 blockers, used
appropriately along with other measures, is now established as standard therapy
for most mild to moderate CHF patients. However, they should not be given to
patients with marked fluid retention and to those requiring i.v. vasodilators
or i.v. inotropic drugs (see Ch. 37).
β blockers help by reducing cardiac
contractile force and aortic pulsation.
β blockers may be used to control tachycardia and arrhythmia, but
should
never be administered
unless an α blocker has been
given before, otherwise dangerous rise in BP can occur. They suppress cardiomyopathy
caused by excess CAs.
Propranolol rapidly controls sympathetic symptoms
(palpitation, nervousness, tremor, fixed stare, severe myopathy and sweating) without
significantly affecting thyroid status. It inhibits peripheral conversion of T4
to T3 and is highly valuable during thyroid storm. Major use,
however, is preoperatively and while awaiting response to antithyroid drugs/
radioactive iodine.
Propranolol is the most effective drug for chronic
prophylaxis of migraine.
Propranolol exerts an apparent antianxiety effect,
especially under conditions which provoke nervousness and panic, e.g.
examination, unaccustomed public appearance, etc. This is probably due to
blockade of peripheral manifestations of anxiety (palpitation, tremor) which
have a reinforcing effect. It is largely ineffective in anxiety neurosis, but
may benefit somatic symptoms.
Nonselective β blockers have now an established place in treating
essential tremor. However, they do not benefit parkinsonian tremor.
Ocular β blockers are widely
used for chronic simple
(wide angle) glaucoma; also used as adjuvant in angle closure glaucoma (see below).
The
subaortic region is hypertrophic. Forceful contraction of this region under
sympathetic stimulation (exercise, emotion) increases outflow resistance which
has incapacitating haemodynamic consequence. β blockers improve c.o.
in these patients during exercise by reducing left ventricular outflow
obstruction, though they have little effect while at rest.
Related Topics
TH 2019 - 2023 pharmacy180.com; Developed by Therithal info.